NCT06787690 (Cohealyx I) is a NA clinical trial of Cohealyx in Burn, sponsored by Avita Medical.

Who is sponsoring NCT06787690?

NCT06787690 is sponsored by Avita Medical.

What drugs are being tested in NCT06787690?

Interventions in NCT06787690: Cohealyx.

What condition does NCT06787690 study?

NCT06787690 studies Burn, Trauma Wound, Full Thickness Wounds, Surgical Wound.

Is NCT06787690 still recruiting?

NCT06787690 is currently active, enrolled. Last updated 10 March 2026.

Last reviewed 2026-03-10 · How we verify

NCT06787690: Cohealyx I

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Prospective Multicenter Single-arm Clinical Study to Investigate Clinical Outcomes When Cohealyx™ is Used for the Management of Full Thickness Wounds Post-surgical Excision

Active, enrolled NA Last updated 10 March 2026

What this trial tests

NA trial testing Cohealyx in Burn in 41 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

15 May 2025

Primary endpoint
10 February 2026

1 August 2026

Quick facts

Lead sponsor	Avita Medical
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	41
Start date	15 May 2025
Primary completion	10 February 2026
Estimated completion	1 August 2026
Sites	18 locations across United States

Drugs / interventions tested

Cohealyx

Conditions studied

Burn — all drugs for Burn →
Trauma Wound — all drugs for Trauma Wound →
Full Thickness Wounds — all drugs for Full Thickness Wounds →
Surgical Wound — all drugs for Surgical Wound →

Sponsor

Avita Medical — full company profile →

Who can join

Eligibility, any sex, with Burn or Trauma Wound. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Time for Cohealyx to generate tissue capable of supporting definitive closure
Time frame: Up to 30 days
Defined as the number of days from placement of Cohealyx until placement of an autologous split-thickness skin graft

Sponsor's own description

The goal of this study is to look at clinical outcomes when Cohealyx Collagen Matrix is used to treat full thickness wounds after surgical excision in patients that require a skin graft to heal their wounds. The main question it aims to answer is how long does it take for Cohealyx to support definitive closure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Burn

Currently open trials in the same condition.

NCT07221903 — The Lateral, Anterior, Medial (LAM) Femoral Cutaneous Block: A Case Series Harborview Medical Center, Seattle, WA · recruiting
NCT06992895 — The Effect of Hologram Application on Pain, Anxiety, and Fear Levels in Children During Burn Dressing · NA · recruiting
NCT07453927 — Blue Light for Donor Site Healing in Burn Patients · NA · recruiting
NCT07025408 — Phase II Clinical Trial of KJ101in the Treatment of Deep II Degree Burns · Phase 2 · recruiting

Other Avita Medical trials

Trials by the same sponsor.

NCT05971381 — Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells · NA · completed
NCT04271501 — Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable · NA · terminated
NCT04547998 — Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions · NA · completed
NCT03626701 — RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years · NA · terminated
NCT04091672 — RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06787690 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Avita Medical
Last refreshed: 10 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06787690.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing